NCT00037427
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
Not specified
Clinical trial condition
Respiratory Hypersensitivity
Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.
4,455 public trials
324 recruiting studies
Respiratory Hypersensitivity trial results
NCT00005425
- Conditions
- Asthma, Bronchial Diseases, Chronic Disease, +12 more
- Locations
-
Not specified
Completed
Asthma Partnership for Minority Children
NCT00005716
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
Not specified
NCT01064869
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Regional Respiratory Centre, Belfast City Hospital Belfast, Co Down, United Kingdom
NCT01323010
- Conditions
- Asthma, Bronchial Diseases, Children, +7 more
- Locations
-
- Instituto da Crianca HCFMUSP São Paulo, Brazil
Completed
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
NCT01357642
- Conditions
- Asthma, Bronchial Diseases, Dyspnea, +11 more
- Locations
-
- West Coast Clinical Trials Costa Mesa, California, United States
- Southern California Institute for Respiratory Diseases Los Angeles, California, United States
- Asthma and Allergy Associates of Southern California Mission Viejo, California, United States
- CHOC PSF, Division of Allergy, Asthma and Immunology Orange, California, United States
NCT01737905
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- West Coast Clinical Trials Global Cypress, California, United States
- The Clinical Research Institute of Southern Oregn, PC Medford, Oregon, United States
- Transitional Clinical Research, Inc. Allergy Associates Research Center Portland, Oregon, United States
- Western Sky Medical El Paso, Texas, United States
NCT01845493
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Environmental Protection Agency at the University of North Carolina Chapel Hill, North Carolina, United States
Completed
"First-in-human" Study To Assess the Safety and Tolerability of PBF-680 in Male Healthy Volunteers
NCT01845181
- Conditions
- Asthma, Bronchial Diseases, Chronic Disease, +11 more
- Locations
-
- Palobiofarma S.L. (molecule owner) Mataró, Barcelona, Spain
- CIM-Sant Pau. Hospital de la Santa Creu i Sant Pau Barcelona, Catalonia, Spain
NCT01939587
- Conditions
- Asthma, Bronchial Diseases, Chronic Disease, +11 more
- Locations
-
- Hospital de la Santa Creu i Sant Pau Barcelona, Spain
- Palobiofarma S.L. (molecule owner) Mataró, Barcelona, Spain